ENTA
Enanta Pharmaceuticals Inc
12.50$
+3.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| 23.4 | – | – | – | 51.8 | 34.0 | 31.8 | 30.1 | 25.0 | 17.1 | 25.9 | 27.6 | 27.0 | 38.0 | 43.3 | 425.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 5.7 | 12.7 | 12.7 | 17.3 | 8.9 | 9.0 | 10.1 | 11.3 | 8.7 | 6.2 | 8.6 | 8.1 | 6.1 | 6.8 | 5.8 | 6.7 | 7.5 | 8.3 | 10.6 | 9.2 | 11.8 | 16.4 | 16.0 | 11.0 | 12.4 | 11.8 | 10.5 | 5.6 | 3.0 | 2.7 | 5.1 | 3.8 | 3.3 | 1.8 | 1.8 | 2.5 | 3.9 | 6.8 | 5.3 | 6.5 | |
| 1.9 | 2.4 | 2.2 | 2.6 | 3.0 | 3.7 | 5.0 | 6.7 | 4.6 | 3.5 | 4.6 | 4.0 | 2.7 | 2.7 | 2.1 | 2.1 | 2.0 | 1.9 | 2.3 | 2.1 | 2.9 | 4.0 | 4.1 | 2.9 | 3.3 | 3.2 | 3.2 | 1.9 | 1.1 | 1.0 | 2.2 | 1.8 | 1.7 | 1.1 | 1.3 | 2.0 | 4.0 | 3.6 | 3.1 | 4.2 | |
| 5.6 | 12.3 | 12.3 | 16.7 | 8.3 | 8.5 | 9.7 | 11.1 | 8.4 | 5.9 | 8.2 | 7.6 | 5.9 | 6.7 | 5.4 | 6.1 | 6.8 | 7.8 | 9.8 | 9.2 | 11.3 | 15.4 | 15.6 | 10.7 | 11.9 | 11.3 | 9.6 | 4.9 | 2.4 | 2.8 | 4.7 | 3.8 | 3.2 | 1.1 | 1.4 | 2.3 | 4.0 | 6.7 | 5.3 | 6.1 | |
| 14.9 | – | – | – | 31.2 | 22.9 | 21.5 | 21.7 | 19.1 | 13.4 | 22.1 | 24.9 | 30.1 | 50.0 | 64.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 16.3 | 116.7 | – | – | 18.3 | 22.5 | 35.4 | 43.8 | 68.6 | 28.2 | 22.9 | 20.8 | 19.0 | 26.7 | 29.5 | 33.9 | 162.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 6.1% | 0.9% | -1.1% | -1.4% | 5.5% | 4.4% | 2.8% | 2.3% | 1.5% | 3.5% | 4.4% | 4.8% | 5.3% | 3.7% | 3.4% | 3.0% | 0.6% | -2.5% | -4.1% | -7.4% | -6.2% | -4.5% | -6.2% | -9.3% | -8.1% | -11.6% | -12.0% | -23.6% | -47.6% | -50.0% | -30.6% | -36.4% | -43.9% | -78.3% | -70.0% | -26.9% | -12.5% | -4.1% | -2.6% | -8.7% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.2% | 98.4% | 97.7% | 97.0% | 97.9% | 98.7% | 99.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 98.3% | 98.1% | |
| 34.9% | -23.5% | -44.9% | -82.5% | 23.9% | 35.3% | 43.7% | 50.2% | 42.7% | 42.7% | 35.7% | 29.3% | 17.9% | 11.6% | 6.4% | -10.3% | -34.0% | -65.7% | -89.9% | -98.5% | -112.9% | -137.3% | -144.0% | -146.0% | -143.7% | -150.4% | -159.0% | -165.3% | -173.2% | -193.0% | -185.8% | -170.7% | -179.9% | -165.7% | -158.4% | -149.4% | -130.7% | -109.1% | -87.2% | -90.0% | |
| 24.5% | -18.9% | -28.7% | -51.9% | 17.2% | 26.3% | 31.6% | 37.6% | 34.8% | 36.2% | 33.3% | 29.2% | 22.6% | 18.0% | 13.5% | 1.6% | -29.5% | -57.0% | -78.6% | -86.2% | -81.4% | -108.4% | -122.7% | -134.2% | -141.3% | -146.9% | -153.6% | -163.9% | -169.0% | -187.8% | -180.8% | -160.3% | -171.6% | -157.6% | -149.6% | -142.0% | -125.4% | -106.8% | -89.6% | -96.9% | |
| 35.2% | 10.9% | -14.4% | -23.8% | 48.8% | 39.7% | 28.4% | 25.8% | 12.7% | 21.9% | 37.7% | 38.7% | 32.2% | 25.6% | 19.8% | 19.8% | 4.6% | -21.0% | -42.8% | -67.4% | -72.9% | -74.5% | -99.4% | -101.8% | -100.9% | -136.5% | -125.4% | -131.8% | -141.7% | -134.7% | -155.4% | -139.4% | -143.0% | -144.9% | -127.6% | -67.2% | -49.2% | -27.6% | -13.9% | -56.6% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| 8.0% | -3.5% | -5.0% | -7.9% | 5.9% | 10.8% | 15.7% | 22.5% | 18.3% | 20.2% | 17.9% | 14.4% | 10.0% | 7.0% | 4.9% | 0.5% | -7.9% | -12.8% | -17.0% | -20.0% | -19.8% | -26.2% | -31.3% | -35.5% | -37.9% | -40.1% | -46.3% | -55.5% | -61.7% | -72.0% | -79.3% | -77.4% | -90.1% | -93.8% | -103.1% | -116.1% | -126.5% | -56.5% | -53.2% | -62.6% | |
| 7.7% | -3.4% | -4.7% | -7.5% | 5.4% | 10.1% | 14.8% | 21.4% | 17.4% | 19.0% | 16.9% | 13.6% | 9.5% | 6.6% | 4.6% | 0.5% | -7.4% | -12.0% | -15.8% | -18.6% | -17.9% | -22.9% | -27.6% | -31.2% | -32.0% | -34.7% | -38.2% | -26.7% | -28.9% | -32.3% | -31.9% | -28.9% | -30.8% | -30.1% | -29.9% | -30.6% | -29.2% | -21.7% | -19.7% | -21.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -16 | -20 | -19 | -22 | -65 | -66 | -64 | -39 | -62 | -73 | -104 | -93 | -50 | -23 | -69 | -96 | -83 | -50 | -72 | 0.4 | -53 | -96 | -38 | -26 | -41 | -39 | -68 | -53 | -45 | 6.5 | -26 | -1.0 | -1.2 | -51 | -27 | -15 | 1.6 | -2.2 | 0.3 | -30 | |
| -0.5 | – | – | – | -2.4 | -1.4 | -0.9 | -0.4 | -0.7 | -0.7 | -1.2 | -1.4 | -1.2 | -0.9 | -4.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 96.0% | 96.3% | 95.4% | 94.6% | 92.4% | 93.2% | 94.0% | 95.2% | 95.0% | 94.0% | 94.5% | 94.6% | 94.4% | 94.4% | 94.6% | 93.9% | 92.8% | 94.0% | 93.2% | 92.8% | 90.6% | 87.2% | 88.1% | 87.7% | 84.4% | 86.6% | 82.5% | 48.0% | 46.9% | 44.8% | 40.2% | 37.3% | 34.2% | 32.1% | 29.0% | 26.3% | 23.1% | 38.4% | 37.0% | 34.0% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 | 0.4 | 0.5 | 0.3 | 0.3 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| 1.14 | -0.50 | -0.70 | -1.08 | 0.90 | 1.73 | 2.54 | 3.86 | 3.42 | 4.15 | 3.69 | 3.06 | 2.22 | 1.63 | 1.19 | 0.12 | -1.80 | -2.88 | -3.67 | -4.15 | -3.91 | -4.94 | -5.47 | -5.79 | -5.91 | -5.79 | -5.93 | -6.27 | -6.35 | -6.56 | -6.22 | -5.45 | -5.48 | -4.94 | -4.51 | -4.32 | -3.83 | -2.49 | -2.13 | -2.17 | |
| 4.64 | 2.64 | 2.43 | 2.08 | 5.24 | 6.55 | 8.04 | 10.25 | 9.81 | 11.46 | 11.10 | 10.48 | 9.83 | 9.04 | 8.83 | 7.50 | 6.10 | 5.06 | 4.67 | 4.81 | 4.80 | 4.56 | 4.46 | 4.32 | 4.18 | 3.94 | 3.86 | 3.83 | 3.76 | 3.49 | 3.44 | 3.40 | 3.19 | 3.14 | 3.02 | 3.04 | 3.06 | 2.33 | 2.38 | 2.24 | |
| 14.18 | 14.09 | 13.97 | 13.67 | 15.38 | 15.94 | 16.18 | 17.17 | 18.69 | 20.51 | 20.69 | 21.23 | 22.15 | 23.22 | 24.39 | 24.00 | 22.70 | 22.50 | 21.62 | 20.68 | 19.75 | 18.85 | 17.45 | 16.32 | 15.60 | 14.45 | 12.81 | 11.30 | 10.29 | 9.10 | 7.85 | 7.03 | 6.08 | 5.26 | 4.38 | 3.72 | 3.03 | 4.40 | 4.01 | 3.47 | |
| 1.63 | 0.29 | -0.35 | -0.50 | 2.56 | 2.60 | 2.29 | 2.65 | 1.25 | 2.51 | 4.18 | 4.05 | 3.16 | 2.31 | 1.74 | 1.48 | 0.28 | -1.06 | -2.00 | -3.24 | -3.50 | -3.40 | -4.43 | -4.39 | -4.22 | -5.38 | -4.84 | -5.04 | -5.33 | -4.70 | -5.35 | -4.74 | -4.56 | -4.54 | -3.85 | -2.04 | -1.50 | -0.64 | -0.33 | -1.27 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.